Learn from the leading researchers in NASH and Fibrosis at NASH-TAG 2018
The NASH-TAG Conference is designed to bring together clinicians and researchers in academia and the pharmaceutical industry for a focused interactive educational update highlighting the most relevant advances and challenges in the diagnosis and therapy of NASH and liver fibrosis. NASH-TAG 2018 will take place over two days providing attendees an understanding of current and future directions in diagnostic procedures, prospects and challenges in drug discovery and development for both NASH and liver fibrosis. Internationally renowned faculty will assist in the development of the educational content and will serve as faculty at the conference.
Clinical trial design
Diagnostic procedures NASH/liver fibrosis
Experimental/basic science, NAFLD/NASH, non-humans
Pathogenesis, translational science, NAFLD/NASH, liver fibrosis, humans
Therapeutic trials NASH/liver fibrosis
ABSTRACT FORMATING INSTRUCTIONS
Limit abstracts to one page, typed in 12-point Times New Roman font, single-spaced with one-inch margins, and left justified. Organize the abstract into Background/Aim, Methods, Results, and Conclusions. Define all abbreviations. Include the abstract category, abstract title, full names and institutional affiliations of all authors, and email address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author. Indicate at the bottom of the page if the abstract has been presented elsewhere and at what meeting. Submitted abstracts not meeting the above specifications will be returned.
Awarded poster abstracts should be printed using landscape orientation (36 inches high x 48 inches long).
Any questions regarding abstract submission should be directed to